Click on image to view larger version.

Figure 1 Power spectral density plots showing the distribution of power (ms²) against frequency (Hz). Representative spectral plots from a subject at baseline and following saline or potassium canrenoate infusion, demonstrating the increase in high-frequency power (0.2 Hz) after active treatment with no significant change in low-frequency power (0.1 Hz) compared to control.